書籍詳細

I. アレルギー疾患の病因・病態

P.16 掲載の参考文献

• 1) Bierman CW, Pearlman DS, Shapiro GG, et al:Allergy, asthma, and immunology from infancy to adulthood. W. B.Saunders, Philadelphia, 1996.

• 2) 多田富雄:免疫学イラストレイテッド. 原著第3版, 南江堂, 1995.

• 3) 笹月健彦:免疫生物学. 免疫系の正常と病理, 南江堂, 1995.

• 4) 菊地浩吉:医科免疫学. 改訂第4版, 南江堂, 1995.

• 5) 古川 漸, 松原和代:肥満細胞-IgE産生系とサイトカイン. Immunohaematology 12:316-320, 1990.

• 6) 笹井敬子, 古川 漸:好酸球と気管支喘息. 小児科 32:1707-1713, 1992.

P.28 掲載の参考文献

• 1) Geha RS:Regulation of IgE synthesis in humans. J Allergy Clin Immunol 90:143-150, 1992.
  pubmed

• 2) Shirakawa T, et al:Association between atopy and variants of the beta subunit of the high-affinity immunoglobulin E receptor. Nature Genetics 7:125-130, 1994.
  pubmed

• 3) Kondo N, et al:FcεRIβ chain gene and Cε chain gene expression. Prediction and prevention of childhood allergy (ed by Sasaki S, et al), p33-43, Chirchill Livingstone, 1995.

• 4) Hill MR, et al:A new variant of the β subunit of the high-affinity receptor for Immunoglobulin E (FcεRI-β E237G):associations with measures of atopy and bronchial hyper-responsiveness. Human Molecular Genet 7:959-962, 1996.

• 5) Fukao T, et al:Association between FcεRIβ and atopic disorder in Japanese population? Lancet 348:407, 1996.

P.37 掲載の参考文献

• 1) 信太隆夫, 安枝 浩:アレルゲンとしての抗原. アレルギーの領域 2(1):7-20, 1995.

• 2) 山田一恵, 宇理須厚雄, 近藤康人ほか:卵白経口摂取による即時型過敏反応と卵白成分に対するIgE結合能. アレルギー48:1201-1209, 1994.

• 3) 中村 良:穀物アレルゲン. 化学と生物 25:739-741, 1987.

• 4) Baur X, Chen Z, Sander I:Isolation and denomination of an important allergen in baking additives:α-amylase from Aspergillus oryzae (Asp II). Clin Exper Allergy 24:465-470, 1993.

• 5) Ishiguro A, Homma M, Torii S, et al:Identification of Candida albicans antigenns reactive with immunoglobulin E antibody of human sera. Infection and Immunity 60(4):1550-1557, 1992.
  pubmed

• 6) Ito H, Ishiguro A, Kanbe T, et al:Characterization of IgE-binding epitopes on Candidaenolase. Clin Exper Allergy 25:529-535, 1995.

• 7) Dong-Hwa Shon, Enomoto A, Yamauchi K, et al:Antibodies raised against peptide fragments of bovine α s1-casein cross react with the native protein, but recognize sites distinct from the determinants on the protein. Eur J Immunol 21:1475-1480, 1991.

• 8) Matthiesen F, Lowenstein H, et al:Group V allergens in grass pollens II Investigation of group V allergens in pollens from 10 grasses. Clin Exp Allergy 21:297-302, 1991.

• 9) Vieths S, Schoning B, Petersen A:Characterization of the 18 kDa apple allergen by two-dimensional immunoblotting and microsequencing. Int Arch Allergy Immunol 104:399-404, 1994.
  pubmed

• 10) Ronald van Ree, Fernandez-Rivas M, Cuevas M, et al:Pollen-related allergy to peach and apple:An important role for profilin. J. Allergy Clin Immunol 95:726-734, 1995.

• 11) 山田一恵, 宇理須厚雄, 駒田英勝ほか:米, 小麦, トウモロコシ, ヒエ, アワの共通アレルゲン性と Rice protein 16 KDの関与. アレルギー40:1485-1492, 1991.

• 12) Thompson PJ, Stewart JA:Allergens Allergy (Holgate ST, Church MK ed), p1.1-1.14, Gower Medical Publishing, London, 1993.

P.44 掲載の参考文献

• 1) Global strategy for asthma. Global strategy for asthma management and prevention. NIH publication number 95-3659, p27, NHLBI/WHO workshop report January 1995.

• 2) 鳥居新平:アレルゲンと室内環境調査. 臨床科学 26:1272-1278, 1990.

• 3) 和田 攻:化学物質による肺障害. 臨床呼吸器病学 (原沢道美編), p611, 朝倉書店, 1982.

• 4) Sandstrom T, et al:Cell response in bronchoalveolar lavage fluid after exposure to sulfur dioxide:a time-response study. Am Rev Resp Dis 140:1828, 1989.
  pubmed

• 5) Kreit JW, et al:Ozone-induced changes in pulmonary function and bronchial responsiveness in asthmaticus. J Appl Physiol 66:217, 1989.

• 6) 小田嶋博ほか:大気汚染物質 (浮遊粒子状物質, 二酸化窒素) と気管支喘息発作入院数との関連. アレルギー44:160, 1995.

• 7) 香川 順:大気汚染による肺疾患. 日本臨牀 (領域別症候群) 3:553, 1992.

• 8) Pope CA, et al:Respiratory health and PM10 pollution:a daily time series analysis. Am Rev Respir Dis 144:668, 1991.
  pubmed

• 9) Takafuji S, et al:Diesel-exhaust particulates inoculated by the intranasal route have an adjuvant activity for IgE production in mice. J Allergy Clin Immunol 79:639, 1987.
  pubmed

• 10) Chilmonczyk BA, et al:Association between exposure to enviromental tabacco smoke and exacerbation of asthma in children. N Engl J Med 328:1665, 1993.

• 11) Weitzman MW, et al:Maternal smoking and childhood asthma. Pediatrics 85:505, 1990.

• 12) Evans D, et al:The impact of passive smoking on emergency room visits of urban children with asthma. Am J Respir Dis 135:567, 1987.

P.51 掲載の参考文献

• 1) 岡堂哲雄:発達臨床心理の理論. 小児ケアのための発達臨床心理, 岡堂哲雄 (監), pp1-37, へるす出版, 東京, 1983.

• 2) 赤坂 徹, 山口淑子, 小原理枝子ほか:施設入院中の気管支喘息児における心身症としての診断基準. 呼吸器心身医学 12:84-87, 1995.

• 3) 赤坂 徹, 根津 進:エゴグラムの小児科領域における標準化とその応用. 心身医学 25:36-44, 1985.

• 4) 赤坂 徹, 山口淑子, 小原理枝子ほか:不登校を主訴とした喘息中学生男子への心身医学的アプローチ. 呼吸器心身医学 12:13-35, 1995.

P.61 掲載の参考文献

• 1) Zeiger RS:Development and prevention of allergic disease in childhood. Allergy Principles and practice, p1137-1171, Mosby-Year book Inc, St. Louis, 1993.

• 2) Bousquet J, et al:Predictive value of tests in childhood allergy. J Allergy Clin Immunol 78:1019-1022, 1986.
  pubmed

• 3) Croner S:Prediction and prevention of allergy development:Influence of genetic and environmental factors. J Pediatr 121:S58-S63, 1992.
  pubmed

• 4) Furukawa S, et al:Neonatal blood IgE levels on filter paper as indicators of atopic disease. Allergy 45:375-381, 1990.
  pubmed

• 5) Sasai K, et al:Early detection of specific IgE antibody against house dust mite in children at risk of atopic disease. J Pediatr 128:834-840, 1996.

• 6) Bjorksten B:Risk factors in early childhood for the development of atopic diseases. Allergy 49:400-407, 1994.
  pubmed

• 7) Friedman NJ, Zeiger RS:Risk factors and prevention of allergy. Allergy, asthma and immunology from infancy to adulthood, p282-295, WB Saunders Company, Philadelphia, 1995.

• 8) Cookson WOCM, et al:Maternal inheritance of atopic responsiveness on chromosome 11q. Lancet 340:381-384, 1992.

II. アレルギー疾患の診断・治療・管理

P.71 掲載の参考文献

• 1) Bierman CW, Pearlman DS, Shapiro GG, et al:Allergy, asthma, and immmology from infancy to adulthood. W. B. Saunders, Philadelphia, 1996.

• 2) 古川 漸, 竹内 透, 津田正晴ほか:小児期における血清IgE値の発達. 最新医学 36:1217-1219, 1981.
  Medical*Online

P.84 掲載の参考文献

• 1) Merkus PJFM, van Essen-Zandvliet EEM, Kouwenberg JM, et al:Large lungs after childhood asthma. Am Rew Respir Dis 148:1484-1489, 1993.

• 2) Woestijine KP, Zapletal A:The maximum expiratory flow-volume curve:peak flow and effort independent portion. In Bouhuys A eds, Airway dynamics-physiology and pharmacology. Springfield III, Thomas, 1970.

• 3) 西間三馨:小児気管支喘息の臨床検査, 換気機能検査. 小児科診療 44:1604-1610, 1981.

• 4) 加野草平, 西間三馨:喘息死に関わる因子の検討-肺機能の面から-. 日小ア誌 9:14-22, 1995.

• 5) 西間三馨, 藤原 崇, 桐野良二:小児気管支喘息の重症発作および軽快時のMEFV曲線の可逆性について. アレルギーの臨床 4:399-400, 1984.

• 6) Turner-Warwick M:On observing patterns of airflow obstruction in chronic asthma. Br J Dis Chest 71:73-86, 197.

• 7) Scheffer AL:International concensus report on diagnosis and treatment of asthma. Clin Exp Allergy 22:39-52, 1992.

• 8) Woodhead M:Guidelines on the management of asthma. Thorax 48 (Suppl):S1-S24, 1993.

• 9) National institute of health:Global initiative for asthma; Global strategy for asthma management and prevention. NHLBI/WHO workshop report. NIH publication No 95-3659, 1995.

• 10) 西間三馨:小児気管支喘息の動脈血液ガス. 日胸 32:405-412, 1977.

• 11) D'alozo GE, Steijijanss VW, Keller A:Measurements of morning and evening airflow grossly underestimate the circadian variability of FEVI and peak expiratory flow rate in asthma. Am J Respir Crit Care Med 152:1097-1099, 1995.

• 12) Reddel HK, Salome CM, Peat JK, et al:Which index of peak expiratory flow is most useful in the management of stable asthma? Am J Respir Crit Care Med 151:1320-1325, 1995.
  pubmed

• 13) Miller MR, Dickinson SA, Hitchings DJ:The accuracy of portable peak flow meters. Thorax 47:904-909, 1992.
  pubmed

P.92 掲載の参考文献

• 1) 佐々木聖:ダニ駆除法とその効果. 小児科診療 54:1133-1138, 1991.

• 2) 安枝 浩:気管支喘息におけるダニアレルゲン. 医学のあゆみ 159:557-559, 1991.
  Medical*Online

• 3) Platts-Mills TAE, Chapman MP:Dust Mites・Immunology, allergic disease and environmental control. J Allergy Clin Immunol 80:755-775, 1987.

• 4) 前田裕二:喘息とアレルゲン. 医学のあゆみ 159:551-556, 1991.
  Medical*Online

• 5) 吉田政弘:厚生省アレルギー総合研究事業研究抄録集 (平成6年度) (企画評価委員長:宮本昭正), p25.

• 6) 佐々木聖:ダニ抗原と気道アレルギー:気道アレルギー'95 (監修牧野荘平・石川 哮):171-191, 1995.

P.103 掲載の参考文献

• 1) Global initiative for asthma. Global strategy for asthma management and prevention, NHLBI/WHO workshop report, NIH publication No. 95-3659, January 1995.

• 2) 日本アレルギー学会アレルギー疾患治療ガイドライン95年改訂版, 牧野荘平 監修, ライフサイエンス・メディカ, 東京, 1995.

• 3) Sears MR, et al:Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 336:1391, 1990.
  pubmed

• 4) Barnes PJ, Pauwels RA:Theophylline in the management of asthma:time for reappraisal? Eur Resp J 7:579, 1994.

• 5) Weinberger M, Hendeles L:Theophylline. Allergy, Principles and Practice, ed. Middleton E. Jr. et al, Mosby, p816, 1993.

• 6) 川勝一雄, 川合 満:テオフィリン, 臨床薬理学と至適投与設計の考え方. Therapeutic Research 8:34, 1988.

• 7) 市川邦男, 岩崎栄作ほか:乳幼児気管支喘息に対するアミノフィリン持続点滴療法の発達薬理学的検討. 日小ア誌 6:75-81, 1992.

• 8) 宮本昭正, 滝島 任ほか:気管支喘息に対するテオフィリンの Round The Clock (RTC) 療法における投与量ガイドライン設定に関する研究. 第IV報テオフィリン徐放製剤 E-0686投与量指針. アレルギー35:250, 1986.

• 9) Kaliner M:Mechanisms of glucocorticosteroid action in bronchial asthma. J Allergy Clin Immunol 76:321-329, 1985.
  pubmed

• 10) Szefler SJ:Glucocorticoid therapy for asthma;Clinical pharmacology. J Allergy Clin Immunol 88:147, 1991.
  pubmed

P.114 掲載の参考文献

• 1) Noon L:Prophylactic inoculation against hay fever. Lancet 1:1572, 1911.

• 2) Freeman J:Further observation on the treatment of hay fever by hypodermic inoculations of pollen vaccine. Lancet 2:814, 1911.

• 3) 中川武正, 大矢直子:1型アレルギー反応とIgG4抗体. 臨床免疫 22:311, 1990.

• 4) 長谷川真紀:減感作療法の免疫学的側面. 医学のあゆみ 9:694, 1991.

• 5) Lichtenstein LM, et al:IgE antibody measurements in ragweed hayfever:Relationships to clinical severity and the results of immunotherapy. J Clin Invest 52:472, 1973.
  pubmed

• 6) Norman PS:Specific therapy in allergy. Med Clin North Am 58:111, 1974.
  pubmed

• 7) Warner JO, et al:Controlled trial of hyposensitization to Dermatophagoides pteronyssinus in children with asthma. Lancet 11:912, 1978.

• 8) Heather S, et al:Allergen immunotherapy decreases Interleukin 4 production in CD4+ T cells from allergic individuals. J Exp Med 178:2123, 1993.

• 9) 須甲松伸:経口減感作療法. 小児内科 22:107, 1990.

P.124 掲載の参考文献

• 1) 椿俊和ほか:アレルギー 43:619, 1994.
  Medical*Online

• 2) 飯倉洋治:アレルギーに克つ生活術, 講談社, 1989.

• 3) 杉本日出雄:喘息に克つ鍛練療法, 光雲社, 1993.

• 4) 松嵜くみ子ほか:アレルギーの領域 2:1629, 1995.

III. アナフィラキシーと全身的な反応

P.136 掲載の参考文献

• 1) 真野健次:アナフィラキシーの原因と病態. アレルギーの領域 1(11):17-22, 1994.

• 2) Slater JE:Rubber anaphylaxis. N Engl J Med 320:1126, 1989.
  pubmed

• 3) Akasawa A, Matsumoto K, Saito H, et al:Incidence of latex allergy in atopic children and hospital worker in Japan. Int Arch Allergy Immunol 101:177-181, 1993.
  pubmed

• 4) Vyas GN, Perkins HA, Yang YM, et al:Healthy blood donors with selective absence of immunoglobulin A:prevention of anaphylactic transfusion reaction caused by antibodies to IgA. J Lab Clin Med 85:838, 1975.

• 5) Capron A, Amerisen JC, Joseph M, et al:New function for platelets and their pathological implication. Int Arch Allergy Appl Immunol 57:206, 1976.

• 6) Brasch RC, Rockoff SD, Kuhn C, et al:Contrast media as histamine liberators. II, Histamine release venous during intravenous pyelography in man. Invest Radiol 5:510-513, 1970.
  pubmed

• 7) Lasser EC, Walters AJ, Lang JH:An experimental basis for histamine release in contrast material reactions. Radiology 110:49-59, 1974.
  pubmed

• 8) Stark BJ, Sullivan TJ:Biphasic and Protracted anaphylaxis. J Allergy Clin Immunol 78:76, 1986.
  pubmed

• 9) Kelly JS, Prielipp RC:Is cimetidine indicated in the treatment of acute anaphylactic shock? Anesth Annalg 71:100, 1990.

• 10) Zaloga GP, DeLacey W, Holmboe E, et al:Glucagon reversal of hypotension in a case of anaphylactoid shock. Ann Intern Med 105:65, 1986.

• 12) Sheffer AL, Austen KF:Exerciseinduced anaphylaxis. J Allergy Clin Immunol 66:106-111, 1980.
  pubmed

• 13) Maulitz RM, Pratt DS, Schocket AL:Exercise-induced anaphylactic reaction to shelfish. J Allergy Clin Immunol 63:433-434, 1979.

• 14) Kidd JM III, Cohen SH, Sosman AJ, et al:Food-dependent exercise-induced anaphylasis. J Allergy Clin Immunol 71:407-411, 1983.

• 15) Sheffer AL, Austen KF:Exercise-induced anaphylaxis. J Allergy Clin Immunol 73:699-703, 1984.
  pubmed

• 16) 須甲松伸, 土肥 真, 奥平博一ほか:運動誘発アナフィラキシー-自験25例の臨床像-. 日本医事新報 3563:18-23, 1992.

• 17) Katunuma T, Iikura Y, Akasawa A, et al:Wheat-dependent exercise-induced anaphylaxis:inhibition by sodium bicarbonate. Ann Allergy 68:184, 1992.

• 18) Juji F, Suko M:Effective of disodium cromoglycate in food-dependent, exercise-induced anaphylaxis:a case report. Ann Allergy 72:452-454, 1994.
  pubmed

• ll) Gullo A, Romano E:Naloxone and anaphylactic shock (letter). Lancet 1:819, 1983.

P.146 掲載の参考文献

• 1) Sly M:Allergic disorders. Textbook of Pediatrics (ed by Behrman RE, et al) 15th. Saunders, Philadelphia, 1996.

P.151 掲載の参考文献

• 1) Nutter A:Contact urticaria to rubber. B J Dermatology 101:597-598, 1979.

• 2) Slater JE, Chhabra SK:Latex allergens. J Allergy Clin Immunol 89:673-678, 1992.

• 3) Kelly K, Pearson M, Kurup V, et al:A cluster of anaphylactic reactions in children with spina bifida during general anesthesia:Epidemiologic features, risk factors, and latex hypersensitivity. J Allergy Clin Immunol 94:53-61, 1994.

• 4) Turjanmaa K:Incidence of immediate allergy to latex gloves in hospital personnel. Contact Dermatitis 17:270-275, 1987.
  pubmed

• 5) Yassin M, Lieri M, Fischer T, et al:Latex allergyin hospital employees. J Allergy Clin Immunol 91:525, 1993.

• 6) Tomazic V, Shampaine E, Lamanna A, et al:Cornstarch powder on latex products is an allergen carrier. J Allergy Clin Immunol 93:751-758, 1994.

• 7) Baur X, Ammon J, Chen Z, et al:Health risk in hospitals through airborne allergens for patients presensitised to latex. Lancet 6 (342):1148-1149, 1993.

• 8) Akasawa A, Matsumoto K, Saito H, et al:Incidence of latex allergy in atopic children and hospital workers in Japan. Int Arch Allergy Immunol 101:177-181, 1993.
  pubmed

• 9) Akasawa A, Hsieh LS, Lin Y:Serum reactivities to Latex proteins (Hevea brasiliensis). J Allergy Clin Immunol 95:1196-1205, 1995.
  pubmed

• 10) Akasawa A, Hsieh LS, Lin Y:Comparison of latex specific IgE binding among nonammoniated latex, ammoniated latex and latex glove allergenic extracts by enzyme linked immunosorbent assay and immunoblot inhibition. J Allergy Clin Immunol (in press).

P.158 掲載の参考文献

• 1) Kelso JM, et al:Anaphylaxis to measles, mumps, and rubella, vaccine mediated by IgE to gelatin. J Allergy Clin Immunol 91:867, 1993.

• 2) 小倉英郎ほか:麻疹ワクチン接種後, アナフィラキシーを来たしたゼラチンアレルギー児の1例. 小児感染免疫 7:115, 1995.

• 3) 小倉英郎:予防接種のすべて, アレルギー疾患-卵アレルギーと予防接種-. 小児科診療 56:2209, 1993.

• 4) 小倉英郎:アレルギー児の予防接種. 小児科診療Q&A, 21号, 赤塚順一ほか編, p1620, 六法出版, 東京, 1995.

• 5) Lund N:Anaphylactic reaction induced by infusion of haemaccel. Br J Anesth 45:929, 1973.

• 6) Freeman MK:Fatal reaction to haemaccel. Anesthesia 34:341, 1979.
  pubmed

• 7) Makino S, et al:A new combined trivalent live measles, mumps, and rubella, vaccine. AJDC 144:905, 1990.
  pubmed

IV. 気管支喘息

P.166 掲載の参考文献

• 1) 牧野荘平:喘息と気道過敏性. アレルギーの診療 9:295, 1987.

• 2) Herxheimer H:The late bronchial reaction in induced asthma. Int Arch Allergy Appl Immunol 3:332, 1952.

• 3) 阿久津郁夫, 福田 健:遅発型喘息反応の病態. 生体防御 7:211, 1990.

• 4) Kay AB:"Helper" (CD4+) T cells and eosinophils in allergy and asthma. Am Rev Respir Dis 145:22, 1992.

• 5) Dunnill MS:The pathology of asthma with special reference to changes in the bronchial mucosa. J Clin Pathol 13:27, 1960.
  pubmed

• 6) Dunnill MS:Masarella GR, Anderson JA:A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis and in emphysema. Thorax 24:176, 1969.

• 7) Kirby JG, Hargreave FE, Gleich G, et al:Bronchoalveolar cell profiles of asthmatic and nonasthmatic subjects. Am Rev Respir Dis 136:379, 1987.
  pubmed

• 8) Wardlaw AJ, Dunnette S, Gleich GJ, et al:Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Am Rev Respir Dis 137:62, 1988.
  pubmed

• 9) Azzawi M, Bradley B, Jeffery, et al:Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis 142:1407, 1990.
  pubmed

• 10) Fukuda T, Ando N, Numao T, et al:Lymphocyte subsets in bronchial mucosa of symptomatic and asymptomatic asthmatics. J Allergy Clin Immunol (abstract) 87:302, 1991.

• 11) Frigas E, Gleich GJ:The eosinophil and the pathophisiology of asthma. Postgrad Course 77:527, 1986.

• 12) Fukuda T, Akutsu I, Motojima S, et al:Inhibition of antigen-induced late asthmatic response and bronchial hyper responsiveness by cyclosporin and FK506. Int Arch Allergy Appl Immunol 94:259, 1991.

• 13) Schleimer RP:Gluco-corticoids ; their mechanisms of actio and use in allergic diseases. In "Allergy, Principles and Practice" 3rd ed(ed. by E Jr Middleton E, Reed CE, EF Ellis EF, et al), Mosby, St. Louis, p739-765, 1988.

• 14) 中島宏和, 福田 健, 安東直彦ほか:気管支喘息患者における気管支粘膜内Tリンパ球浸潤の副腎皮質ステロイド剤による抑制. アレルギー42(4):505, 1993.

• 15) Mosmann TR, et al:Two types of murine helper T cell clonel. Definition ancording to profiles of lymphokine activities and secreted proteins. J Immunol:138, 2348, 1986.

• 16) 阿久津郁夫, 牧野荘平:免疫抑制剤の可能性. 喘息, 5(4):79, 1992.

• 17) 茆原順一, 中島重徳:好酸球のレセプター. 治療 25:23, 1991.

• 18) Hammid Q, Azzawi N, Ying S, et al:Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest 87:1541, 1991.

• 19) Fukuda T, Nakajima H, Fukushima Y, et al:Detection of interleukin-5 messenger RNA and interleukin-5 protein in bronchial biopsies from asthma by nonradioactive in situ hybridization and immunohisto-chemistry. J Allergy Clin Immunol 94:584, 1994.

• 20) Robinson DS, Hamid Q, Ying S, et al:Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 326:298, 1992.
  pubmed

• 21) Walker C, Bode E, et al:Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis 146:109, 1992.
  pubmed

• 22) Wong DTW, Weller PF, Galli SJ, et al:Human eosinophils express transforming growth factor J Exp Med 172:673, 1990.

• 23) Brach MA, Sott C, Kiehntopf, et al:Expression of the transforming factor-a gene by human eosinophils is regulated by interleukin-3, interleukin-5, and granulocyte-macrophage colony-stimulating factor. Eur J Immunol 24:646, 1994.

• 24) Moqbel R, Hamid Q, Ying S, et al:Expression of mRNA and immunoreactivity for the granulocyte/macrophage colony-stimulating factor in activated human eosinophils. J Exp Med 174:749, 1991.
  pubmed

• 25) Fujisawa T, Fukuda S, Atsuta R, et al:Interferon-gamma induces interleukin-3 release from peripheral blood eosinophils. Int. Arch. Allergy Immunol 104 (suppl):41, 1994.

• 26) Lim K, Wan HC, Resnick M, et al:Human eosinophils release the lymphocyte and eosinophil active cytokines, RANTES and lymphocyte chemotactic factor. Int Arch Allergy Immunol 107:342, 1995.

• 27) Miyamasu M, Hirai K, Takahashi Y, et al:Chemotactic agonists induce cytokine generation in eosinophils J Immunol 154:1339, 1995.
  pubmed

• 28) Kita H, Abu-Ghazaleh RI, Sur S, et al:Eosinophil major basic protein induces degranulation and IL-8 production by human eosinophils. J Immunol 154:4749, 1995.
  pubmed

• 29) Moqbel R, Ying S, Barkans J, et al:Identification of messeger RNA for IL-4 in human eosinophils with granule localization and release of the translated product. J Immunol 155:4939, 1995.

• 30) Levi Schaffer F, Lacy P, Severs NJ, et al:Association of granulocyte-macrophage colony-stimulating factor with the crystalloid granules of human eosinophils. Blood 85:2579, 1995.
  pubmed

• 31) Nonaka M, Nonaka K, Woolley E, et al:Distinct immunochemical localization of IL-4 in human inflamed airway tissues. IL-4 is localized to eosinophils in vivo and is released by peripheral blood eosinophils. J Immunol 155:3234, 1995.

• 32) Dubucquoi S, Desreumaux P, Janin A, et al:Interleukin 5 synthesis by eosinophils:Association with granules and immunoglobulin-dependent secretion. J Exp Med 179:703, 1994.
  pubmed

• 33) Butterfield JH, Leiferman KM, Abrams J, et al:Elevated serum levels of interleukin-5 in patients with the syndrome of episodic angioedema and eosinophilia. Blood 79:688, 1992.
  pubmed

• 34) Sedwick JB, Calhoun WJ, Gleich GJ, et al:Immidiate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators. Am Rev Respir Dis 144:1274, 1991.

• 35) Lopez AF, Sanderson CJ, Gamble JR, et al:Recombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med 167:219, 1988.
  pubmed

• 36) Fujisawa T, Abu-Gazaleh Kita H, et al:Regulatory effect of cytokines on eosinophil degranulation. J Immunol 144:642, 1990.

• 37) Nakajima H, Gleich GJ, Kita H:Constitutive production of IL-4 and IL-10 and stimulated production of IL-8 by normal peripheral blood eosinophils. J Immunol 156:4859, 1996.
  pubmed

P.176 掲載の参考文献

• 1) 三河春樹:小児気管支喘息の疫学. 小児内科 28:176-178, 1996.

• 2) 西間三馨:西日本小学児童の気管支喘息罹患率調査. アレルギー42:192-204, 1993.

• 3) Global Initiative for Asthma, Global Strategy for Asthma Management and Prevention, NHLBI/WHO Workshop Report, p24-38, 1995.

• 4) 馬場 実:アレルギー疾患の発症とその展開. 第31回日本小児アレルギー学会講演集小児アレルギー疾患研究の進歩, p191-199,1995.

• 5) 永山洋子:乳幼児の喘鳴. 小児科診療 57:184-186, 1994.

• 6) 古庄巻史他:小児気管支喘息の発作の程度, 重症度, 予後判定基準検討委員会報告, 日本小児アレルギー学会誌 10(2):114-119, 1996.

P.189 掲載の参考文献

• 1) Barnes PJ, et al:J Allergy Clin Immunol 83:1013-1026, 1989.
  pubmed

• 2) Beasley R, et al:Am Rev Respir Dis 139:806-817, 1989.
  pubmed

• 3) 馬場 実:小児内科 28:159-161, 1996.

• 4) Kips JC, et al:Int Arch Allergy Immunol 99:478-481, 1992.
  pubmed

• 5) Sullivan P, et al:Lancet 343:1006-1008, 1994.
  pubmed

• 6) 森川みきほか:日小ア誌 9:46-53, 1995.

• 7) 市川邦男ほか:日小ア誌 6:75-81, 1992.

• 8) 日本アレルギー学会:アレルギー疾患治療ガイドライン (改訂版), ライフサイエンス・メディカ, 東京, 1995.

P.194 掲載の参考文献

• 1) 向山徳子, 馬場 実, 北嶋征男ほか:小児気管支喘息の予後調査成績. 小児科診療 38:1349-1358, 1975.

• 2) 松井猛彦, 向山徳子, 馬場 実:小児気管支喘息発症15〜28年後の長期予後. アレルギー29:805-815, 1980.

• 3) 向山徳子:アレルギーにおける治癒の可能性. 小児喘息. 第12回 免疫薬物療法研究会記録集, p64-74, メディカルトリビューン, 東京, 1995.

• 4) 小児アレルギー研究会:小児気管支喘息の発作の程度・重症度予後判定基準. 日本小児アレルギー学会誌 2:65-72, 1988.

• 5) Buffum WP, Settipane GA:Prognosis of asthma in childhood. Am J Dis Child 112:214-217, 1966.
  pubmed

• 6) Blair H:Natural history of childhood asthma, 20-year follow-up. Arch Dis Child 52:613-619, 1977.
  pubmed

• 7) 宮林容子, 向山徳子, 馬場 実:小児気管支喘息の臨床経過と呼吸機能・気道過敏性についての検討. 日本小児アレルギー学会誌 6:68-74, 1992.

• 8) 秋山一男, 三上理一郎, 可部順三郎ほか:成人気管支喘息の新しい分類の提唱-小児発症喘息, 成人発症喘息, 成人再発喘息. アレルギー41:727-738, 1992.

P.202 掲載の参考文献

• 1) 三松高一:小児気管支喘息の病歴の検討. Prog Med 10:1271-1283, 1990.
  Medical*Online

• 2) Umeno E, et al:Hypertonic saline increases vasucular permeability in the rat trachea by producing neurogenic inflammation. J Clin Invest 85:1905-1908, 1990.

• 3) 西間三馨:水泳と喘息. 小児内科 14:375-380, 1982.

• 4) Anderson SD, et al:Exercise-induced asthma. Br J Dis Chest 69:1-39, 1975.
  pubmed

• 5) 古賀龍夫:喘息児のEIB誘発試験におけるWBPLAによる至適負荷量の検討. 日児誌 93:1174-1182, 1989.

• 6) 荒木速雄:運動誘発喘息の評価と運動処方. 小児内科 28:255-262, 1996.

• 7) 荒木速雄:スポーツ活動とアレルギー. アレルギーの臨床 11:499-503, 1991.

• 8) 進藤宗洋ほか:持久性トレーニングによるEIBの改善. 体育科学 20:29-37, 1992.

• 9) 荒木速雄:水泳トレーニング. アレルギーの臨床 13:321-325, 1993.

• 10) 大坪庸子:臨床的に診断したFEA9例の臨床的検討と追跡調査 (日本小児アレルギー学会誌に投稿中).

P.207 掲載の参考文献

• 1) Szczeklik A:Aspirin-induced asthma:New insights into pathogenesis and clinical presentation of drug intolerance. Int Arch Allergy Appl Immunol 90:70-75, 1989.
  pubmed

• 2) 鈴木真砂:アスピリン喘息の背景因子に関する臨床的研究. 藤田学園医学会誌 8:149-185, 1989.

• 3) 榊原博樹, 津田美奈子, 鈴木真砂ほか:水溶性アスピリン (アスピリンDL-リジン製剤, Venopirin (R) の吸入によるアスピリン喘息の診断. 日本胸部疾患 学会誌 26:275-283, 1988.

• 4) 宇理須厚雄, 森田 豊, 近藤康人:小児のアスピリン喘息. 小児科 36:1497-1995, 1995.

• 5) Szczeklik A, Nizankowska E, Czerniawska-Mysik G, et al:Hydrocortisone and airflow impairment in aspirin-induced asthma. J Allergy Clin Immunol 76:530-536, 1985.
  pubmed

• 6) 山口公一, 馬場 実:ステロイドによるアレルギー. 小児科 30:959-962, 1989.

• 7) 山本英明, 永田 真, 倉光 薫ほか:アスピリン喘息とロイコトリエン拮抗薬. 臨床医薬 9:326, 1993.

P.215 掲載の参考文献

• 1) 松井猛彦:気管支喘息児の手術. 小児科 26:145-154, 1985.

• 2) 柳川 進:気管支喘息児の全身麻酔, 発作予防と術前処置についての検討. 日小会誌 99:947-953, 1995.

• 3) Gold MI, Helrich M:A study of the complications related to anesthesia in asthmatic patients. Anesth. Analog 42:283-293, 1963.

• 4) Mallampathi SR:Bronchospasum during spinal anesthesia. Anesth. Analog 60:839-840, 1981.

• 5) 松井猛彦, 市川邦男, 馬場 実:気管支喘息児の術中・術後発作と合併症. 日本医事新報 3187:24-29, 1985.

• 6) Converse JG, Smotrilla MM:Anesthesia and the asthmatic. Anesth. Analog 40:363-342, 1961.

• 7) 赤坂 徹, 中山喜弘, 村野順三ほか:小児気管支喘息死亡の最近の動向, 昭和46〜54年までの9年間の全国統計. 小児科 22:925-934, 1981.

• 8) 安田信彦, 高木 康:喘息患者の手術. 外科診療 23:545-551, 1995.

• 9) 三河春樹, 馬場 実ほか:小児気管支喘息の診断と治療. 日本アレルギー学会アレルギー疾患治療ガイドライン95年改訂版, p55-82, ライフサイエンス・メディカ, 東京, 1995.

• 10) 野崎京子, 安宅一晃, 寺沢嘉之ほか:気管支喘息患者の麻酔, 最近10年間の集計より. 住友医誌 19:159-162, 1992.

• 11) Mittman C:Assesment of operative risk in thoracicsurgery. Am. Rerv. Respir. Dis 84:197-207, 1961.

• 12) 篠原正一, 稲本 晃:いわゆる気管支痙攣症の統計的観察. 麻酔 14:612-619, 1965.

V. 慢性肺疾患

P.222 掲載の参考文献

• 1) 安藤正幸:原澤道美ほか (編), 呼吸器疾患-state of arts 1995-'98-, p363, 医歯薬出版, 1994.

• 2) 徳山研一ほか:日児誌 87:664, 1983.

• 3) Reiss JS, et al:Ann Allergy 32:208, 1974.
  pubmed

• 4) Cunningham AS, et al:Pediatrics 58:436, 1976.
  pubmed

• 5) 影山さち子ほか:小児内科 16:1539, 1984.

• 6) Mizobe T, et al:J Clin Microbiol 31:1949, 1993.
  pubmed

P.227 掲載の参考文献

• 1) Hinson KF, et al:Thorax 73:317, 1952.

• 2) Rosenberg M, et al:Ann Intern Med 86:405, 1977.
  pubmed

• 3) 平松和子ほか:診断と治療 81:1217, 1993.

VI. 皮膚疾患

P.235 掲載の参考文献

• 1) Tanaka Y, et al:Immunohistochemical studies in mite antigen-induced patch test sites in atopic dermatitis. J Dermatol Sci 1:361-368, 1990.
  pubmed

• 2) Tanaka Y, et al:High affinity IgE receptor(FcεR1) expression on eosinophils infiltrating the lesions and mite-patch tested sies in atopic dermatitis. Arch Dermatol Res 287:712-717, 1995.

• 3) Tanaka Y, et al:Interleukin-5 messenger RNA and immunoreactive protein expression by activated eosinophils in lesional atopic dermatitis skin. J Invest Dermatol 103:589-592, 1994.
  pubmed

• 4) Bieber T, et al:Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (FcεRI). J Exp Med 175:1285-1290, 1992.

• 5) Gounni AS, et al:High-affinity IgE receptor on eosinophils in involved in defence against parasites. Nature 367:183-186, 1994.
  pubmed

• 6) Maurer D, et al:Expression of fuctional high affinity immunoglobulin E receptors(FcεRI) on monocytes of atopic dermatitis. J Exp Med 179:745-750, 1994.

• 7) Okada S, et al:The presence of immunoglobulins and their receptors on epidermal Langerhans cells in atopic dermatitis. J Dermatol 23:247-253, 1996.

• 8) Tanaka M, et al:High affinity IgE receptor (FcεRI) mediated prostaglandin E2 production by monocytes in atopic dermatitis. Int Arch Allergy Immunol 108:247-253, 1995.

• 9) Hamid Q, et al:Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest 94:870-876, 1994.
  pubmed

• 10) Grewe M, et al:Lesional expression of interferon-g in atopic eczema. Lancet 343:25-26, 1994.

• 11) Ohmen JD, et al:Overexpression of IL-10 in atopic dermatitis. J Immunol 154:1956-1963, 1995.
  pubmed

• 12) Simon MR, et al:Antigen presenting cell-independent cytokine and spontaneous in vitro IgE production in patients with atopic dermatitis:Increased interferon-g production and lack of effects of in vivo low-dose interferon-g treatment. J Allergy Clin Immunol 96:84-91, 1995.

• 13) Chan SC, et al:Altered prostaglandin E2 regulation of cytokine production in atopic dermatitis. J Immunol 151:3345-3352, 1993.
  pubmed

• 14) Kennedy MK, et al:Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J Immunol 149:2496-2505, 1992.

• 15) Rus V, et al:Kinetics of Th1 and Th2 cytokine production during the early couse of acute and chronic murine graft-versus-host disease. J Immunol 155:2396-2406, 1995.

• 16) Vowels BR, et al:Th2 cytokine mRNA expression in situ in cutaneous T-cell lymphoma. J Invest Dermatol 103:669-673, 1994.

• 17) Romagnani S:Lymphokine production by human T cells disease states. Annu Rev Immunol 12:227-257, 1994.

P.247 掲載の参考文献

• 1) Scientific committee of the Japanese dermatological association:Definition and diagnostic criteria for atopic dermatitis by the Japanese Dermatological Association. J Dermatol 23:141-142, 1996.

• 2) 今村榮一:アトピー性皮膚炎の手引き-厚生省による小児のアトピー性皮膚炎の全国調査. 日小皮会誌 12(1):83-85, 1993.

• 3) Muto M, Matsushita S, Nakano J, et al:Role of HLA-linked genes relevant to genetic predisposition to immunological diseases. Advances in Allergy & Immunol 1:161-170, 1992.

P.253 掲載の参考文献

• 1) Jones HE, Inouye JC, McGerity JL, et al:Atopic disease and serum immunoglobulin-E. Br J Dermatol 92:17-25, 1975.
  pubmed

• 2) Ogawa M, Berger PA, McIntyre OR, et al:IgE in atopic dermatitis. Arch Dermatol 103:575-580, 1971.
  pubmed

• 3) 亀山富雄:アトピー性皮膚炎におけるRASTの検討. アレルギー26:521-526, 1977.

• 4) 神田源太, 阿南貞雄, 赤星吉徳ほか:アトピー性皮膚炎におけるfood allergy-食餌アレルゲンに対するIgEならびにIgG4抗体について. 皮膚 26:611-616, 1984.

• 5) 向山徳子:食物が関与したアトピー性皮膚炎の診断と治療手順. 小児科臨床 49:467-479, 1996.
  Medical*Online

• 6) 高路 修, 沼田恒実, 矢野貴彦ほか:アトピー性皮膚炎における皮内反応と白血球からの抗原特異ヒスタミン遊離の検討. アレルギー32:624, 1983.

• 7) 山本昇壯:アトピー性皮膚炎とケミカル・メディエーター. アレルギーの臨床 7:926-931, 1987.

• 8) Barr RM, Koro O, Francis DM, et al:The release of prostaglandin D2 from human skin in vivo and in vitro during immediate allergic reactions. Br J Pharmacol 94:773-780, 1988.
  pubmed

• 9) Davies MG, Greaves MW:The current status of histamine receptors in human skin:therapeutic implications. Br J Dermatol 104:601-606, 1981.
  pubmed

P.266 掲載の参考文献

• 1) 須貝哲郎:全身性接触皮膚炎および接触アレルギーによる異常な表現. 皮膚 30:8-18, 1988.

• 2) Lepoittevin JP, Drieghe J, Dooms-Goossens A:Studies in patients with corticosteroid contact allergy. Arch Dermatol 131:31-37, 1995.
  pubmed

P.272 掲載の参考文献

• 1) 吉田彦太郎:蕁麻疹. 臨床アレルギー学 (宮本昭正監修), p248-258, 南江堂, 東京, 1992.

• 2) 田中豊道, 田中洋一, 計森幸子ほか:ダニ抽出液による接触蕁麻疹の1例. 皮膚 28:344-347, 1986.

• 3) Nutter AF:Contact urticaria to rubber. BJ Dermatology 101:597-598, 1979.

• 4) Kelly KJ, Pearson ML, Kurup VP, et al:A cluster of anaphylactic reactions in children with spina bifida during general anesthesia:Epidemiologic features, risk factors, and latex hypersensitivity. J Allergy Clin Immunol 94:53-61, 1994.
  pubmed

• 5) Makinen-Kiljunen S:Banana allergy in patients with immediate type hypersensitivity to natural latex:characterisation of cross-reacting anti-bodies and allergens. J Allergy Clin Immunol 93:990-996, 1994.

• 6) 大柳小百合, 大柳 聡, 水谷 仁ほか:アトピー性皮膚炎の看護婦に発生したセフォチアムによる接触葦麻疹症候群の1例. 日皮アレルギー3:194-196, 1995.

• 7) 船坂陽子, 市橋正光:日光蕁麻疹. 皮膚科 Mook, 蕁麻疹(山本昇壯編集企画), p80-87, 金原出版, 東京, 1988.

• 8) 白石聡:Angioedema. 皮膚科 Mook, 蕁麻疹 (山本昇壯編集企画), p164-169, 金原出版, 東京, 1988.

VII. 食物アレルギー

P.282 掲載の参考文献

• 1) Metcalfe DD:Food Allergy. In Ogra PL, et al, editor:Handbook of mucosal immunology. p493-504, San Diego, Academic Press Inc, 1994.

• 2) Sampson HA, et al:Fatal and near-fatal food anaphylactic reactions to food in children and adolescents. N Engl J Med 327:380, 1992.
  pubmed

• 3) Kauppinen K, et al:Urticaria in children. Allergy 39:469-472, 1984.
  pubmed

• 4) Champion RH, et al:Urticaria and angioedema:a review of 554 patients. Br J Dermatol 81:588-597, 1969.
  pubmed

• 5) Burks AW, et al:Atopic dermatitis:clinical relevance of food hypersensitivity reactions. J pediatr 113:447-451, 1988.
  pubmed

• 6) Bock SA, et al:Patterns of food hypersensitivity during sixteen years of double-blind placebo-controlled food challenges, J pediatr 117:561-567, 1990.
  pubmed

• 7) Sampson HA, et al:Food-induced respiratory reactions in children with atopic dermatitis (abstract). J Allergy Clin Immunol 83:241, 1989.

• 8) Silverman M, et al:Clinical physiology of food intolerance in asthma. In Reed CE, editor:Proceedings, XIIth Interational Congress of Allergology and Clinical Immunology, p457-462, St Louis, CV Mosby, 1986.

• 9) Wilson N, et al:Diagnosis of food sensitivity in childhood asthma. JR Soc Med, 78 (supple 5), p11-16, 1988.

• 10) Onorato J, et al:Placebo-controlled double-blind food challenge in asthma. J Allergy Clin Immunol 78:1139-1146, 1986.
  pubmed

• 11) Heiner DC, et al:Chronic respiratory disease associated with multiple circulating precipitins to cow's milk. Am J Dis Child 100:500-502, 1960.

• 12) Amlot PL, et al:Oral allergy syndrome:symptoms of IgE-mediated hypersensitivity to foods. Clin Allergy 17:33-42, 1987.
  pubmed

• 13) Sampson HA:Food Allergy. J Allergy Clin Immunol 84:1062-1067, 1989.
  pubmed

• 14) Weber RF, et al:Food and migraine headache. Immunol Allergy Clin North Am 11:831-841, 1991.

• 15) Sieniawska M, et al:The role of cow's milk protein intolerance in steroid-resistant nephrotic syndrome. Acta Pediatr 81:1007-1012, 1992.

• 16) Sampson HA:Immunologically mediated food allergy:the importance of food challenge procedures. Ann Allergy 60:262-269, 1988.
  pubmed

P.290 掲載の参考文献

• 1) Well H:Studies on the chemistry of anaphylaxis III Experiments with isolated proteins, especially those of hen'egg. J Infect Dis 9:147-153, 1911.

• 2) Friedman A, Weiner HL:Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc Natl Acad Sci USA 91(14):6688-6692, 1994.
  pubmed

• 3) Hirahara H, Hisatsune T, Nishijima K, et al:CD4' T cells anergized by high dose feeding establish oral tolerance to antibody responses when transferred in SCID and nude mice. J Immunol 154:6238-6245, 1995.

• 4) Fujihashi K, Kiyono H, Aicher WK, et al:Immunoregulatory function of CD3', CD4 and CD8 T cell yδ T cell receptor-positive T cells from nude mice abrogate oral tolerance. J Immunol 143:3415-3422, 1989.

• 5) Urisu A, Ando H, Morita V, et al:Allergenic activity of heated and ovomucoid-deleted egg white (投稿中).

• 6) 坂本龍雄:消化管アレルギー(抄). アレルギー25(2・3):210, 1996.

• 7) Borgatze RF:Distinct roles of L-selection and integrins alpha 4 beta 7 and LFA-1 in lymphocyte homing to Peyer's patch-HEY in situ:the multistep model confirmed and refined. Immunity 3(1):99-108, 1995.

• 8) 山田一恵, 宇理須厚雄, 駒田英勝ほか:米, 小麦, トウモロコシ, ヒエ, アワの共通アレルゲン性と Rice protein 15 KD の関与. アレルギー40:1485-1492, 1991.

• 9) 山田一恵, 宇理須厚雄, 近藤康人ほか:卵白経口摂取による即時型過敏反応 と卵白成分に対するIgE結合能. アレルギー43(9):1201-1209, 1994.

• 10) 鳥居新平:アレルギーとn-6/n-3比-その臨床的意義-. 脂質栄養学 4(1):56-63, 1995.

• 11) 鳥居新平, 山田政功, 菊池 哲ほか:n-3系列多価不飽和脂肪酸強化食のアトピー性皮膚炎に対する効果-n-3系列多価不飽和脂肪酸強化食品イパオールを用いた多施設 placebo controlled cross over trial による検討-. 日本小児アレルギー学会誌 9(2):67-75, 1995.

• 12) Zeiger RS, Heller Susan:The development and prediction of atopy in high risk children:Follow-up at age seven years in a prospective randomized study of combined maternal and infant food allergen avoidance. J Allergy Clin Immunol 95:1179-1190, 1995.

• 13) Tari MG, Mancino M, Monti G:Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study. Allergol et Immunopathol 18(5):277-284, 1990.
  pubmed

• 14) Van Niekerk CH, De Wet JL:Efficacy of grass-maize pollen oral immunotherapy in patients with seasonal hayfever:Double blind study. Clin Allergy 17:507-513, 1987.

• 15) Enomoto A, Konishi M, Hachimura S, et al:Milk whey protein fed as a constituent of the diet induced both oral tolerance and a systemic humoral response, while heat-denatured whey protein induced only oral tolerance. Clin Immunol Immunopathol 66:136-142, 1993.

• 16) Tani H, Matzuda T, Nakamura R:Enhancing effect of malondialdehyde modification on the mouse IgE response to protein antigens. Agric Biol Chem 54:2323-2330, 1990.

VIII. 鼻アレルギー(花粉症を含む)

P.307 掲載の参考文献

• 1) 奥田 稔:どう分類するか. 鼻アレルギー. 第2版, p34-36, 金原出版, 東京, 1988.

• 2) 奥田 稔:好酸球増多性鼻炎. 鼻アレルギー. 第2版, p226-227, 金原出版, 東京, 1992.

• 3) 宇佐神篤:鼻アレルギー(主要鑑別診断). アレルギー診療マニュアル, 中村晋, 寺道由晃, 中澤次夫編, p191-193, 金原出版, 東京, 1993.

• 4) Mullarkey MF, et al:J Allergy Clin Immunol 65:122-126, 1980.
  pubmed

• 5) Jacobs RL, et al:J Allergy Clin Immunol 67:253-262, 1981.
  pubmed

• 6) 宇佐神篤:高齢者の鼻アレルギーとその類似疾患, 第2回静岡県耳鼻咽喉科 アレルギー研究会講演録, p1-8, 1993.

• 7) 宇佐神篤, 植田尚男, 野口 恒:長期調査からみたスギ花粉症の動向, アレルギーの臨床. 16(3):178-182, 1996.

• 8) 宇佐神治子, 宇佐神篤, 石田岳志ほか:アンケート調査にみられた静岡県下の学童・生徒のアトピー性皮膚炎 (第一報) -アトピー性皮膚炎の有病率-. 日本皮膚科学会会誌 104(2):89-97, 1994.

• 9) 宇佐神篤:小児鼻アレルギーの予後, 第3回小児気管支喘息治療研究会記録集, p40-46, 1995.

• 10) 宇佐神篤:鼻アレルギーの疫学および予後, アレルギー診療マニュアル, 中村晋, 寺道由晃, 中澤次夫編, p73-77, 金原出版, 東京, 1993.

• 11) 宇佐神篤:アレルギー性疾患の臨床的な推移-耳鼻科の立場より, No.9免疫薬物療法研究会記録集, p113-123, メディカルトリビューン, 東京, 1992.

• 12) 浜口富美, 鵜飼幸太郎, 原田 泉ほか:小児鼻アレルギーにおよぼす成長の影響. アレルギー33(6):308-317, 1984.

• 13) 山岸益夫ほか:小児鼻アレルギーの長期経過. 耳喉 59(2):135-140, 1987.

• 14) 馬場廣太郎, 谷垣内由之ほか:スギ花粉症の自然治癒について. 耳鼻 37:1187-1191, 1991.

• 15) 芦田恒雄, 榎本雅夫, 衛藤幸男ほか:スギ花粉症の自然治癒. アレルギー44(3-2):406-406, 1995.

• 16) 宇佐神篤:花粉症の臨床像. JOHNS 4(2):228-234, 1988.

• 17) 岸川禮子, 長野 準:スギ花粉症患者の発症年齢と地域差. 図説スギ花症, 改訂第二版, 信太隆夫, 奥田稔編, p60-61, 金原出版, 東京, 1991.

• 18) 宇佐神篤:鼻アレルギー(病因論), アレルギー診療マニュアル, 中村晋, 寺道由晃, 中澤次夫編, p107-111, 金原出版, 東京, 1993.

• 19) 宇佐神篤:花粉症の現況. アレルギーの臨床 1(4):29-33, 1981.

• 20) 奥田 稔:効果の判定, 薬効検定法. 鼻アレルギー. 第2版, p271-274, 金原出版, 東京, 1988.

• 21) 奥田稔:誘発試験鼻アレルギー. 第2版, p176-187, 金原出版, 東京, 1992.

• 22) 宇佐神篤:鼻粘膜誘発テスト, アレルギー診療マニュアル, 中村晋, 寺道由晃, 中澤次夫編, p251-255, 金原出版, 東京, 1993.

• 23) 奥田稔:特異的減感作 (免疫) 療法は基本的治療法である. 鼻アレルギー. 第二版, p241-263, 金原出版, 東京, 1992.

• 24) 奥田 稔:ケミカルメジエター遊離抑制薬. 鼻アレルギー. 第2版, p281-285, 金原出版, 東京, 1992.

IX. アトピーと眼疾患

P.319 掲載の参考文献

• 1) Holgate ST, Chuch MK:Allergy, p19. 1-20.8, Gower Medical Publishing, New York, 1993.

• 2) 石崎道治, 高橋佳二:花粉によるアレルギー性結膜炎の新しい考え方と治療. 日本の眼科 66:640, 1995.

• 3) 石崎道治:眼結膜誘発試験. 臨床免疫 20:198-202, 1988.

• 4) 石崎道治, 鈴木康意, 森 純一ほか:スギ花粉性結膜炎の疫学調査と重症度分類. 日本の眼科 67:651-657, 1996.

• 5) 石崎道治, 小暮文雄, 森沢 康:アレルギー性結膜炎患者の環境と背景調査. アレルギー35:342-348, 1986.

• 6) 湯浅武之助, 中川やよい, 多田玲:春季カタル. 眼科Mook 33:64-84, 1987.

• 7) Trocme SD, Kephart GM, Allasmith MR, et al:Conjunctival deposition of eosinophil granule major basic protein in vernal keratoconjunctivitis and contact lens-associated giant papillary conjunctivitis. Am J Ophthalmol 108:57-63, 1989.

• 8) 石崎道治:春季カタル. 眼科 37:1263-1269, 1993.

• 9) Hogan MJ:Atopic keratoconjunctivitis. Am J Ophthalmol 36:937-947, 1953.
  pubmed

• 10) Smolin G, O'Conner GR:Ocular Immonology, p174-178, little, Brown and Company, Boston, 1986.

• 11) Hanifin JM, Rajka G:Diagnostic features of atopic dermatitis. Acta Derm. Venereol 92:44, 1980.

• 12) Jay JL:Clinical features and diagnosis of adult atopic keratocunjunctivitis and the effect of treatment with sodium cromoglycate. Br J Ophthalmol 65:335-340, 1981.
  pubmed

• 13) Uehara M, Amemiya T, Arai M:Atopic cataracts in a Japanese population. Dermatologica 170:180-184, 1985.

• 14) 勝島晴美, 宮崎幾代, 関根伸子ほか:アトピー性皮膚炎における白内障および網膜剥離の合併頻度. 日眼会誌 98:495-500, 1994.

• 15) 徳田久弥:眼科における薬の使用法. p139-150, メディカル葵出版, 東京, 1985.

X. 消化管アレルギー

P.333 掲載の参考文献

• 1) Sampson HA:Adverse reactions to foods. Allergy principles and practice. p1661-1686, Mosby-Year book Inc, St. Louis, 1993.

• 2) Seidman EG, et al:Gastroenterologic and liver disorders in infants and children. Immunologic disorders in infants and children, p503-541, WB Saunders Company, Philadelphia, 1989.

• 3) Childers NK:Molecular mechanisms of immunoglobulin a defense. Annu Rev Microviol 43:503-536, 1989.
  pubmed

• 4) Sasai K, et al:IgE levels in fecal extracts of patients with food allergy. Allergy 47:594-598, 1992.
  pubmed

• 5) Strobel S:Mechanisms of tolerance and sensitization in the intestine and other organs of the body. Allergy 50(suppl 18-25), 1995.

• 6) 名倉 宏:腸管における抗原処理と提示. 臨床免疫 28:145-152, 1995.

• 7) 吉開泰信:腸管におけるγδ細胞と生体防御. 臨床免疫 28:162-167, 1995.

• 8) 楠美昭則ほか:粘膜免疫系におけるIgA産生の調節-サイトカイン遺伝子欠如マウスを応用した解析. 臨床免疫 28:153-161, 1995.

• 9) Stern M:Gastrointestinal allergy. Pediatric gastrointestinal disease. p557-573, B C Decker Inc, Philadelphia, 1991.

• 10) Hoffman KM, et al:Adverse reactions to foods. Allergy, asthma and immunology from infancy to adulthood, p672-675, WB Saunders Company, Philadelphia, 1995.

• 11) Katz AJ, et al:Milk-sensitive and eosinophilic gastroenteropathy:Similar clinical feature with contrasting mechanisms and clinical course. J Allergy Clin Immunol 74:72-78, 1984.
  pubmed